(R) - 7 - (2 - (1 - (4-butoxyphenyl) - 2 - metilpropan - 2 - ilamino) - 1-hydroxyethyl) - 5 - hidroxibenzo [d] thiazole - 2 (3H) - One； Preparation Process； Pharmaceutical Combination containing Composition and use in treatment； and and Prevention of muscular dystrophy, disuse atrophy or cachexia, sarcopenia.

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

NICOLA TUFILLI,JUN CAO,BERNHARD ERB,ROBIN ALEC FAIRHURST,ARNAUD GRANDEURY,SHINJI HATAKEYAMA,MAGDALENA KOZICZAK-HOLBRO,XINZHONG LAI,PHILIPP LUSTENBERGER,THOMAS ULLRICH,XIANG WU,JIANGUANG ZHOU,BERN RIEB

申请号：

CL2014000493

公开号：

CL2014000493A1

申请日:

2014.02.27

申请国别(地区):

CL

年份:

2014

代理人:

摘要：

The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form a method for manufacturing the compound of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and pharmaceutical compositions.EL COMPUESTO (R)-7-(2-(1-(4-BUTOXIFENIL)-2-METILPROPAN-2-ILAMINO)-1-HIDROXIETIL)-5-HIDROXIBENZO[D]TIAZOL-2(3H)-ONA； PROCEDIMIENTO DE PREPARACIÓN； COMPOSICIÓN Y COMBINACIÓN FARMACÉUTICA； ÚTILES PARA PREPARAR UN MEDICAMENTO PARA EL TRATAMIENTO O PREVENCIÓN DE LA DISTROFIA MUSCULAR, ATROFIA POR DESUSO, CAQUEXIA O SARCOPENIA.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/